The involvement of TGF-β1 /FAK/α-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in ratsRehab F. Abdel‐Rahman, Marawan A. Elbaset, Alyaa F. Hessin et al.|PLoS ONE|2021Cited by 48
Nrf2/<scp>HO</scp>‐1, <scp>NF‐κB</scp> and <scp>PI3K</scp>/Akt signalling pathways decipher the therapeutic mechanism of pitavastatin in early phase liver fibrosis in ratsMarawan A. Elbaset, Hany M. Fayed, Sherif M. Afifi et al.|Journal of Cellular and Molecular Medicine|2024Cited by 32
Apigenin role against thioacetamide-triggered liver fibrosis: Deciphering the PPARγ/TGF-β1/NF-κB and the HIF/FAK/AKT pathwaysRehab F. Abdel‐Rahman, Hanan A. Ogaly, Marawan A. Elbaset et al.|Journal of Herbmed Pharmacology|2023Cited by 24
Repositioning gemigliptin for the alleviation of thioacetamide-induced liver fibrosis in rats: Targeting TLR4/MAPK, SIRT1/AMPK/Nrf2, PI3K/AKT/mTOR axis and apoptosisRiyadh S. Almalki, Marawan A. Elbaset, Sherif M. Afifi et al.|European Journal of Pharmaceutical Sciences|2025Cited by 15
Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR PathwayMarawan A. Elbaset, Hany M. Fayed, Sherif M. Afifi et al.|Advances in Pharmacological and Pharmaceutical Sciences|2024Cited by 10